Jessen B, Rodriguez-Sillke Y, Sonnenberg E, Schumann M, et al. Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab. Clin Gastroenterol Hepatol 2021;19:721-731.
PMID: 32272247